Home › Auxilium Licenses Vivus ED Drug in $300M Deal
 

Keywords :   


Auxilium Licenses Vivus ED Drug in $300M Deal

2013-10-12 03:51:34| Biotech - Topix.net

Auxilium Pharmaceuticals will get the right to sell Vivus' impotence drug Stendra in the U.S. and Canada as part of a deal between the two companies that could be worth more than $300 million.

Tags: deal drug licenses 300m

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
03.07Keep livestock safe during hurricane season with an emergency plan
03.07Making the most of forage resources
03.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Forecast Discussion Number 17
02.07Hurricane Beryl Forecast Advisory Number 17
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
More »